Disc Medicine Inc. (IRON)
Disc Medicine Statistics
Share Statistics
Disc Medicine has 34.57M shares outstanding. The number of shares has increased by 20.57% in one year.
| Shares Outstanding | 34.57M |
| Shares Change (YoY) | 20.57% |
| Shares Change (QoQ) | 0.11% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 21.77M |
| Failed to Deliver (FTD) Shares | 2.12K |
| FTD / Avg. Volume | 0.56% |
Short Selling Information
The latest short interest is 2.04M, so 5.96% of the outstanding shares have been sold short.
| Short Interest | 2.04M |
| Short % of Shares Out | 5.96% |
| Short % of Float | 11.35% |
| Short Ratio (days to cover) | 7.47 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is -10.56. Disc Medicine's PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | -10.56 |
| PS Ratio | 0 |
| Forward PS | 3.4 |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Disc Medicine Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 21.17, with a Debt / Equity ratio of 0.07.
| Current Ratio | 21.17 |
| Quick Ratio | 21.17 |
| Debt / Equity | 0.07 |
| Total Debt / Capitalization | 6.33 |
| Cash Flow / Debt | -3.13 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is null% and return on capital (ROIC) is -19.27%.
| Return on Equity (ROE) | null% |
| Return on Assets (ROA) | null% |
| Return on Capital (ROIC) | -19.27% |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-909,869.05 |
| Employee Count | 84 |
| Asset Turnover | null |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 99K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -15.84% in the last 52 weeks. The beta is 2.85, so Disc Medicine's price volatility has been higher than the market average.
| Beta | 2.85 |
| 52-Week Price Change | -15.84% |
| 50-Day Moving Average | 54.91 |
| 200-Day Moving Average | 52.7 |
| Relative Strength Index (RSI) | 43.93 |
| Average Volume (20 Days) | 375.64K |
Income Statement
| Revenue | n/a |
| Gross Profit | -100K |
| Operating Income | -91.13M |
| Net Income | -76.43M |
| EBITDA | -91.03M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -3.42 |
Balance Sheet
The company has 192.43M in cash and 30M in debt, giving a net cash position of 162.43M.
| Cash & Cash Equivalents | 192.43M |
| Total Debt | 30M |
| Net Cash | 162.43M |
| Retained Earnings | -298M |
| Total Assets | 496.77M |
| Working Capital | 470.3M |
Cash Flow
In the last 12 months, operating cash flow was -93.93M and capital expenditures -505K, giving a free cash flow of -94.43M.
| Operating Cash Flow | -93.93M |
| Capital Expenditures | -505K |
| Free Cash Flow | -94.43M |
| FCF Per Share | 0 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IRON does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -6.53% |
| FCF Yield | -5.21% |
Analyst Forecast
The average price target for IRON is $75, which is 43.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $75 |
| Price Target Difference | 43.1% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
Stock Splits
The last stock split was on Dec 30, 2022. It was a backward split with a ratio of 1:10.
| Last Split Date | Dec 30, 2022 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | 20.16 |
| Piotroski F-Score | 2 |